FDA Approves New Alzheimer's Drug, Bringing Hope of Slowing Disease for US Patients The US Food and Drug Administration (FDA) gave a green light to Eli Lilly's Kisunla, a new Alzheimer's drug that slightly delays the disease's progression. by Inno Flores
Apple Unveils iPhone 16 Pro Specs and AI Integration With Major Updates in Battery Tech and Messages App
Google Scrambles to Reduce Reliance on Safari Amid Antitrust Battle, Blocking Users From Using AI Features